"For 2026, we are maintaining our cash operating expense guidance of less than $390 million." (CFO & President of Recursion UK Taylor). "We expect multiple clinical readouts over the next 12 to 18 ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Good morning, everyone, and thank you for joining us. Since stepping into this role, I've been focused on a singular question: how do we harness the full power of AI to consistently and with urgency ...

Earnings call Recursion Pharmaceuticals delivered strong operational progress with a 30% YoY reduction in operating expenses and an extended cash runway into early 2028. Clinical momentum was ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

The quintessential pink eraser is now a mainstay in household junk drawers, classrooms, and office supply cabinets, but how ...

Roughly three-quarters of American workers plan to work for pay after they retire, according to the 2026 Retirement Confidence Survey from the Employee Benefit Research Institute. But only 31% of ...

The ‘Backrooms’ monster torments Clark (Chiwetel Ejiofor) and Dr. Mary Kline (Renate Reinsve), alongside other mysteries—here ...

Born from a single unsettling image, this viral horror concept from Kane Parsons wears thin under the weight of a full ...

In The Lancet in 1971, Julian Tudor Hart gave medicine one of its most important insights: the availability of medical care ...

EPS exceeded forecasts by 15.38%, reflecting effective cost management. Revenue missed expectations by 60.26%, raising concerns about growth prospects. The stock price fell by 5.34% in pre-market ...

Once you're in, you're in.